Spiegel Robert J. — SEC insider filings

SEC reporting owner CIK 1492256. 56 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers the 50 most recent of 56 filings on record, filed 2021-06-17 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RenovoRx, Inc. (RNXT)Director61 leg · 40,983 sh—6
GERON CORP (GERN)Director29——31
Athenex, Inc. (ATNX)Director8——10
Cyclacel Pharmaceuticals, Inc. (CYCC)Director3——6
Old Ayala, Inc (AYLA)Director2——5
Ayala Pharmaceuticals, Inc. (ADXS)Director1——4
Ernexa Therapeutics Inc. (ERNA)Director1———

Insider filings — Spiegel Robert J.

FiledFormIssuerReported transactionsSource
2026-10-024RenovoRx, Inc. (RNXT)Grant/award (A): 55,924 (derivative) @ $0EDGAR
2026-10-014GERON CORP (GERN)Grant/award (A): 6,351 @ $1.23EDGAR
2026-09-223Ernexa Therapeutics Inc. (ERNA)Holdings only — no transactions reportedEDGAR
2026-07-014GERON CORP (GERN)Grant/award (A): 6,103 @ $1.28EDGAR
2026-05-264GERON CORP (GERN)Grant/award (A): 220,000 (derivative) @ $0EDGAR
2026-04-014GERON CORP (GERN)Grant/award (A): 5,243 @ $1.49EDGAR
2026-01-054GERON CORP (GERN)Grant/award (A): 5,918 @ $1.32EDGAR
2025-10-024RenovoRx, Inc. (RNXT)Grant/award (A): 47,640 (derivative) @ $0EDGAR
2025-10-014GERON CORP (GERN)Grant/award (A): 5,702 @ $1.37EDGAR
2025-07-014GERON CORP (GERN)Grant/award (A): 5,540 @ $1.41EDGAR
2025-05-224GERON CORP (GERN)Grant/award (A): 180,000 (derivative) @ $0EDGAR
2025-04-024/AGERON CORP (GERN)Grant/award (A): 2,462 @ $3.30 · Grant/award (A): 1,916 @ $4.24EDGAR
2025-04-024/AGERON CORP (GERN)Grant/award (A): 1,767 @ $4.54EDGAR
2025-04-024/AGERON CORP (GERN)Grant/award (A): 2,206 @ $3.54EDGAR
2025-04-024GERON CORP (GERN)Grant/award (A): 4,913 @ $1.59EDGAR
2025-01-024GERON CORP (GERN)Grant/award (A): 2,206 @ $0EDGAR
2024-10-024RenovoRx, Inc. (RNXT)Grant/award (A): 25,099 (derivative) @ $0EDGAR
2024-10-014GERON CORP (GERN)Grant/award (A): 1,767 @ $0EDGAR
2024-06-284GERON CORP (GERN)Grant/award (A): 2,462 @ $0 · Grant/award (A): 1,916 @ $0EDGAR
2024-05-104GERON CORP (GERN)Grant/award (A): 180,000 (derivative) @ $0EDGAR
2024-01-304RenovoRx, Inc. (RNXT)Purchase (P): 40,983 · Purchase (P): 40,983 (derivative)EDGAR
2024-01-034GERON CORP (GERN)Grant/award (A): 3,406 @ $0EDGAR
2023-10-024GERON CORP (GERN)Grant/award (A): 3,390 @ $0EDGAR
2023-10-024RenovoRx, Inc. (RNXT)Grant/award (A): 25,099 (derivative) @ $0EDGAR
2023-07-034Cyclacel Pharmaceuticals, Inc. (CYCC)Grant/award (A): 21,219 @ $0 · Grant/award (A): 42,438 (derivative) @ $0EDGAR
2023-06-304GERON CORP (GERN)Grant/award (A): 2,239 @ $0EDGAR
2023-06-024GERON CORP (GERN)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2023-04-274RenovoRx, Inc. (RNXT)Grant/award (A): 43,026 (derivative) @ $0EDGAR
2023-04-244Athenex, Inc. (ATNX)Grant/award (A): 2,300 @ $1.30EDGAR
2023-04-034GERON CORP (GERN)Grant/award (A): 3,312 @ $0EDGAR
2023-01-234Ayala Pharmaceuticals, Inc. (ADXS)Grant/award (A): 3,279 (derivative) · Grant/award (A): 2,342 (derivative) · Grant/award (A): 1,171 (derivative) · Grant/award (A): 1,171 (derivative)EDGAR
2023-01-234Old Ayala, Inc (AYLA)Disposition to issuer (D): 17,500 (derivative) · Disposition to issuer (D): 12,500 (derivative) · Disposition to issuer (D): 6,250 (derivative) · Disposition to issuer (D): 6,250 (derivative)EDGAR
2023-01-174Athenex, Inc. (ATNX)Grant/award (A): 16,130 @ $0.19EDGAR
2023-01-034GERON CORP (GERN)Grant/award (A): 2,970 @ $0EDGAR
2022-10-124Athenex, Inc. (ATNX)Grant/award (A): 12,453 @ $0.24EDGAR
2022-10-034GERON CORP (GERN)Grant/award (A): 3,071 @ $0EDGAR
2022-08-304Athenex, Inc. (ATNX)Option exercise (M): 8,750 · Option exercise (M): 8,750 (derivative) @ $0EDGAR
2022-07-214Athenex, Inc. (ATNX)Grant/award (A): 4,508 @ $0.67EDGAR
2022-07-014GERON CORP (GERN)Grant/award (A): 4,637 @ $0EDGAR
2022-06-294Athenex, Inc. (ATNX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2022-06-164Cyclacel Pharmaceuticals, Inc. (CYCC)Grant/award (A): 15,822 @ $0 · Grant/award (A): 31,645 (derivative) @ $0EDGAR
2022-06-154Ayala Pharmaceuticals, Inc. (AYLA)Grant/award (A): 6,250 (derivative) @ $0EDGAR
2022-05-114GERON CORP (GERN)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2022-04-114Athenex, Inc. (ATNX)Grant/award (A): 3,989 @ $0.75EDGAR
2022-04-014GERON CORP (GERN)Grant/award (A): 5,284 @ $0EDGAR
2022-01-034GERON CORP (GERN)Grant/award (A): 5,891 @ $0EDGAR
2021-10-014GERON CORP (GERN)Grant/award (A): 5,246 @ $0EDGAR
2021-08-054Athenex, Inc. (ATNX)Grant/award (A): 8,750 (derivative) @ $0 · Grant/award (A): 8,750 (derivative) @ $0EDGAR
2021-07-014GERON CORP (GERN)Grant/award (A): 5,097 @ $0EDGAR
2021-06-174Cyclacel Pharmaceuticals, Inc. (CYCC)Grant/award (A): 2,374 @ $0 · Grant/award (A): 4,748 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1492256 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs